皮肤和软组织感染(SSTIs)耐甲氧西林金黄色葡萄球菌(MRSA)分离株nahco3应答表型的表型和基因型相关性

IF 8.7 1区 医学 Q1 INFECTIOUS DISEASES Clinical Microbiology and Infection Pub Date : 2025-04-01 Epub Date: 2024-12-01 DOI:10.1016/j.cmi.2024.11.034
Selvi C. Ersoy , Sabrina L. Madrigal , Liang Chen , Jose Mediavilla , Barry Kreiswirth , Evelyn A. Flores , Loren G. Miller , Yan Q. Xiong , Ewan M. Harrison , Beth Blane , Sharon J. Peacock , Robin Patel , Henry F. Chambers , Arnold S. Bayer , Richard A. Proctor
{"title":"皮肤和软组织感染(SSTIs)耐甲氧西林金黄色葡萄球菌(MRSA)分离株nahco3应答表型的表型和基因型相关性","authors":"Selvi C. Ersoy ,&nbsp;Sabrina L. Madrigal ,&nbsp;Liang Chen ,&nbsp;Jose Mediavilla ,&nbsp;Barry Kreiswirth ,&nbsp;Evelyn A. Flores ,&nbsp;Loren G. Miller ,&nbsp;Yan Q. Xiong ,&nbsp;Ewan M. Harrison ,&nbsp;Beth Blane ,&nbsp;Sharon J. Peacock ,&nbsp;Robin Patel ,&nbsp;Henry F. Chambers ,&nbsp;Arnold S. Bayer ,&nbsp;Richard A. Proctor","doi":"10.1016/j.cmi.2024.11.034","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><div>The objective of this study is to assess the frequency of the novel sodium bicarbonate (NaHCO<sub>3</sub>)-responsive phenotype, wherein clinical methicillin-resistant <em>Staphylococcus aureus</em> (MRSA) isolates are rendered susceptible to standard-of-care β-lactams in the presence of NaHCO<sub>3</sub>, in a collection of 103 clinical U.S. MRSA skin and soft-tissue infection (SSTI) isolates and 22 clinical European SSTI isolates. This study determined the correlation between specific phenotypic and genotypic metrics and the NaHCO<sub>3</sub>-responsive phenotype among U.S. SSTI isolates.</div></div><div><h3>Methods</h3><div>Antimicrobial susceptibility testing was performed to determine susceptibility phenotypes. Targeted and whole-genome sequencing with a genome-wide sequence analysis were conducted to identify specific and novel genotypes of interest that may be associated with the NaHCO<sub>3</sub>-responsive phenotype. Gene expression analysis and targeted gene deletion were performed to assess the role of a specific novel genetic locus in the NaHCO<sub>3</sub>-responsive phenotype.</div></div><div><h3>Results</h3><div>The NaHCO<sub>3</sub>-responsive phenotype was identified in 78/103 U.S. isolates and 4/22 UK isolates to cefazolin (CFZ), and in 17/103 U.S. isolates and 1/22 UK isolates to oxacillin. In U.S. isolates, a significant association was identified between NaHCO<sub>3</sub>-responsiveness to CFZ and: (a) susceptibility to amoxicillin–clavulanate; (b) a specific <em>mecA</em> genotype; (c) clonal complex type 8; and (d) <em>spa</em> type t008. Genome-wide sequence analysis identified single nucleotide polymorphisms (SNPs) in an AraC family regulator (SAUSA300_RS00540) to be exclusively found in NaHCO<sub>3</sub>-non-responsive SSTI strains. <em>In vitro</em> HCO<sub>3</sub> exposures of NaHCO<sub>3</sub>-responsive strains, but not -non-responsive strains, caused &gt;2-fold upregulated expression of this gene. Deletion of this gene rendered NaHCO<sub>3</sub>-responsive strain MRSA 11/11 no longer NaHCO<sub>3</sub>-responsive to CFZ; we have termed this gene the staphylococcal AraC bicarbonate-response regulator.</div></div><div><h3>Discussion</h3><div>NaHCO<sub>3</sub>-responsiveness is highly associated with clonal complex type 8/<em>spa</em> type t008, a commonly circulating genetic background in North America. The AraC bicarbonate-response regulator, staphylococcal AraC bicarbonate-response regulator, appears to be associated with the mechanism of NaHCO<sub>3</sub>-responsiveness, but more work is needed to verify.</div></div>","PeriodicalId":10444,"journal":{"name":"Clinical Microbiology and Infection","volume":"31 4","pages":"Pages 588-593"},"PeriodicalIF":8.7000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Phenotypic and genotypic correlates of the sodium bicarbonate-responsive phenotype among methicillin-resistant Staphylococcus aureus isolates from skin and soft-tissue infections\",\"authors\":\"Selvi C. Ersoy ,&nbsp;Sabrina L. Madrigal ,&nbsp;Liang Chen ,&nbsp;Jose Mediavilla ,&nbsp;Barry Kreiswirth ,&nbsp;Evelyn A. Flores ,&nbsp;Loren G. Miller ,&nbsp;Yan Q. Xiong ,&nbsp;Ewan M. Harrison ,&nbsp;Beth Blane ,&nbsp;Sharon J. Peacock ,&nbsp;Robin Patel ,&nbsp;Henry F. Chambers ,&nbsp;Arnold S. Bayer ,&nbsp;Richard A. Proctor\",\"doi\":\"10.1016/j.cmi.2024.11.034\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objectives</h3><div>The objective of this study is to assess the frequency of the novel sodium bicarbonate (NaHCO<sub>3</sub>)-responsive phenotype, wherein clinical methicillin-resistant <em>Staphylococcus aureus</em> (MRSA) isolates are rendered susceptible to standard-of-care β-lactams in the presence of NaHCO<sub>3</sub>, in a collection of 103 clinical U.S. MRSA skin and soft-tissue infection (SSTI) isolates and 22 clinical European SSTI isolates. This study determined the correlation between specific phenotypic and genotypic metrics and the NaHCO<sub>3</sub>-responsive phenotype among U.S. SSTI isolates.</div></div><div><h3>Methods</h3><div>Antimicrobial susceptibility testing was performed to determine susceptibility phenotypes. Targeted and whole-genome sequencing with a genome-wide sequence analysis were conducted to identify specific and novel genotypes of interest that may be associated with the NaHCO<sub>3</sub>-responsive phenotype. Gene expression analysis and targeted gene deletion were performed to assess the role of a specific novel genetic locus in the NaHCO<sub>3</sub>-responsive phenotype.</div></div><div><h3>Results</h3><div>The NaHCO<sub>3</sub>-responsive phenotype was identified in 78/103 U.S. isolates and 4/22 UK isolates to cefazolin (CFZ), and in 17/103 U.S. isolates and 1/22 UK isolates to oxacillin. In U.S. isolates, a significant association was identified between NaHCO<sub>3</sub>-responsiveness to CFZ and: (a) susceptibility to amoxicillin–clavulanate; (b) a specific <em>mecA</em> genotype; (c) clonal complex type 8; and (d) <em>spa</em> type t008. Genome-wide sequence analysis identified single nucleotide polymorphisms (SNPs) in an AraC family regulator (SAUSA300_RS00540) to be exclusively found in NaHCO<sub>3</sub>-non-responsive SSTI strains. <em>In vitro</em> HCO<sub>3</sub> exposures of NaHCO<sub>3</sub>-responsive strains, but not -non-responsive strains, caused &gt;2-fold upregulated expression of this gene. Deletion of this gene rendered NaHCO<sub>3</sub>-responsive strain MRSA 11/11 no longer NaHCO<sub>3</sub>-responsive to CFZ; we have termed this gene the staphylococcal AraC bicarbonate-response regulator.</div></div><div><h3>Discussion</h3><div>NaHCO<sub>3</sub>-responsiveness is highly associated with clonal complex type 8/<em>spa</em> type t008, a commonly circulating genetic background in North America. The AraC bicarbonate-response regulator, staphylococcal AraC bicarbonate-response regulator, appears to be associated with the mechanism of NaHCO<sub>3</sub>-responsiveness, but more work is needed to verify.</div></div>\",\"PeriodicalId\":10444,\"journal\":{\"name\":\"Clinical Microbiology and Infection\",\"volume\":\"31 4\",\"pages\":\"Pages 588-593\"},\"PeriodicalIF\":8.7000,\"publicationDate\":\"2025-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical Microbiology and Infection\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1198743X24005652\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/12/1 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"INFECTIOUS DISEASES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Microbiology and Infection","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1198743X24005652","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/12/1 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

摘要

目的:评估新型NaHCO3反应表型的频率,其中临床耐甲氧西林金黄色葡萄球菌(MRSA)分离株在NaHCO3存在下对标准护理β-内酰胺敏感,收集103例临床美国MRSA皮肤和软组织感染(SSTI)分离株和22例临床欧洲SSTI分离株。确定美国SSTI分离株特异性表型和基因型指标与nahco3应答表型之间的相关性。方法:采用药敏试验(AST)测定药敏表型。采用靶向和全基因组测序(WGS)和全基因组序列分析(GWAS)来鉴定可能与nahco3应答表型相关的特定和新的基因型。通过基因表达分析和靶向基因缺失来评估一个特定的新基因位点在nahco3应答表型中的作用。结果:78/103美国分离株和4/22英国分离株对头孢唑林(CFZ)有nahco3应答表型,17/103美国分离株和1/22英国分离株对oxacillin (OXA)有nahco3应答表型。在美国分离株中,nahco3对CFZ的反应性与以下因素之间存在显著关联:1)对阿莫西林-克拉维酸盐的敏感性;ii)特定的mecA基因型;iii)克隆复合物(CC) 8型;iv) spa型t008。GWAS发现AraC家族调节因子(SAUSA300_RS00540)的snp只存在于nahco3无应答的SSTI菌株中。在体外暴露于HCO3的nahco3应答菌株,而非nahco3应答菌株,导致该基因的表达上调2倍。该基因的缺失使MRSA 11/11对nahco3反应的菌株对CFZ不再有nahco3反应;我们将该基因命名为葡萄球菌AraC碳酸氢盐反应调节因子,简称sabR。结论:nahco3反应性与CC8/spa t008高度相关,CC8/spa t008是北美常见的遗传背景。AraC对碳酸氢盐的反应调节因子sabR似乎与nahco3的反应机制有关,需要更多的工作来验证。字数288。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Phenotypic and genotypic correlates of the sodium bicarbonate-responsive phenotype among methicillin-resistant Staphylococcus aureus isolates from skin and soft-tissue infections

Objectives

The objective of this study is to assess the frequency of the novel sodium bicarbonate (NaHCO3)-responsive phenotype, wherein clinical methicillin-resistant Staphylococcus aureus (MRSA) isolates are rendered susceptible to standard-of-care β-lactams in the presence of NaHCO3, in a collection of 103 clinical U.S. MRSA skin and soft-tissue infection (SSTI) isolates and 22 clinical European SSTI isolates. This study determined the correlation between specific phenotypic and genotypic metrics and the NaHCO3-responsive phenotype among U.S. SSTI isolates.

Methods

Antimicrobial susceptibility testing was performed to determine susceptibility phenotypes. Targeted and whole-genome sequencing with a genome-wide sequence analysis were conducted to identify specific and novel genotypes of interest that may be associated with the NaHCO3-responsive phenotype. Gene expression analysis and targeted gene deletion were performed to assess the role of a specific novel genetic locus in the NaHCO3-responsive phenotype.

Results

The NaHCO3-responsive phenotype was identified in 78/103 U.S. isolates and 4/22 UK isolates to cefazolin (CFZ), and in 17/103 U.S. isolates and 1/22 UK isolates to oxacillin. In U.S. isolates, a significant association was identified between NaHCO3-responsiveness to CFZ and: (a) susceptibility to amoxicillin–clavulanate; (b) a specific mecA genotype; (c) clonal complex type 8; and (d) spa type t008. Genome-wide sequence analysis identified single nucleotide polymorphisms (SNPs) in an AraC family regulator (SAUSA300_RS00540) to be exclusively found in NaHCO3-non-responsive SSTI strains. In vitro HCO3 exposures of NaHCO3-responsive strains, but not -non-responsive strains, caused >2-fold upregulated expression of this gene. Deletion of this gene rendered NaHCO3-responsive strain MRSA 11/11 no longer NaHCO3-responsive to CFZ; we have termed this gene the staphylococcal AraC bicarbonate-response regulator.

Discussion

NaHCO3-responsiveness is highly associated with clonal complex type 8/spa type t008, a commonly circulating genetic background in North America. The AraC bicarbonate-response regulator, staphylococcal AraC bicarbonate-response regulator, appears to be associated with the mechanism of NaHCO3-responsiveness, but more work is needed to verify.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
25.30
自引率
2.10%
发文量
441
审稿时长
2-4 weeks
期刊介绍: Clinical Microbiology and Infection (CMI) is a monthly journal published by the European Society of Clinical Microbiology and Infectious Diseases. It focuses on peer-reviewed papers covering basic and applied research in microbiology, infectious diseases, virology, parasitology, immunology, and epidemiology as they relate to therapy and diagnostics.
期刊最新文献
Real-world influenza surveillance and vaccine effectiveness in children: a multicentre study of the Italian Federation of Primary Care Paediatricians (FIMP). Extended-pulsed fidaxomicin versus conventional dosing in patients at high risk of recurrence of Clostridioides difficile infection: a multicentre cohort study. Reporting of antibiotic resistance in randomized controlled trials of new antibiotics: a systematic review. Which trial do we need? Treatment of severe measles. Extracting added value from existing tests - use of quantitative results from tuberculosis infection tests to improve the ability to predict progression to TB disease.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1